首页> 美国卫生研究院文献>other >Thymineless Death in F10-Treated AML Cells Occurs via Lipid Raft Depletion and Fas/FasL co-Localization in the Plasma Membrane with Activation of the Extrinsic Apoptotic Pathway
【2h】

Thymineless Death in F10-Treated AML Cells Occurs via Lipid Raft Depletion and Fas/FasL co-Localization in the Plasma Membrane with Activation of the Extrinsic Apoptotic Pathway

机译:F10处理的AML细胞中无胸腺嘧啶的死亡是通过脂质筏耗尽和Fas / FasL在血浆膜中共定位并激活外源性凋亡途径而发生的。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The polymeric fluoropyrimidine F10 displays excellent anti-leukemia activity in pre-clinical models of acute myelogenous leukemia (AML) through dual targeting of thymidylate synthase and DNA topoisomerase 1. Here we report that F10 activates the extrinsic apoptotic pathway in AML cells by enhancing localization of Fas and Fas ligand (FasL) at the plasma membrane and while reducing overall lipid raft levels promotes Fas/FasL co-localization in remaining lipid rafts. The HMG-CoA synthase inhibitor simvastatin was synergistic with F10 and induced cell death via similar apoptotic processes. Our results are consistent with diverse processes activating a common apoptotic pathway characterized by reduced overall levels of lipid rafts and Fas/FasL co-localization in the plasma membrane, including in remaining lipid rafts which may play a role in both cell-survival and cell death signaling.
机译:通过对胸苷酸合酶和DNA拓扑异构酶1的双重靶向,多聚氟嘧啶F10在临床前的急性粒细胞性白血病(AML)模型中显示出优异的抗白血病活性。 Fas和Fas配体(FasL)在质膜上,同时降低了整体脂质筏的水平,促进了Fas / FasL在剩余脂质筏中的共定位。 HMG-CoA合酶抑制剂辛伐他汀与F10协同作用,并通过类似的凋亡过程诱导细胞死亡。我们的结果与激活共同凋亡途径的多种过程相一致,该过程以脂质筏的总体水平降低和质膜中Fas / FasL共定位为特征,包括可能在细胞存活和细胞死亡中起作用的剩余脂质筏中的总水平。信号。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号